GlassScriptPhysician profile
Chantal L Hamlin
NPI 1124792015
$1,424.07
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $191 · 2022: $745 · 2023: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469 · Education: $20.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.73 |
| Education | $20.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $172.00 | 2021-2023 | Gattex |
| Amgen INC. | $165.81 | 2022-2023 | Tavneos, Epogen, Parsabiv |
| Vifor Pharma, INC. | $150.93 | 2021-2023 | Korsuva, Veltassa |
| Aurinia Pharma U.S., INC. | $102.18 | 2021-2023 | Lupkynis |
| Daiichi Sankyo INC. | $97.18 | 2021-2022 | |
| Opko Pharmaceuticals, LLC | $96.33 | 2022-2023 | Rayaldee |
| Glaxosmithkline, LLC. | $93.74 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $75.70 | 2022-2023 | Terlivaz |
| Ultragenyx Pharmaceutical INC. | $67.82 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $66.37 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.04 | 2021-2023 | Jardiance |
| Ani Pharmaceuticals, INC. | $50.74 | 2022-2023 | Purified Cortrophin Gel |
| Travere Therapeutics, INC. | $43.45 | 2022-2023 | |
| Fresenius USA Marketing, INC. | $39.91 | 2021-2023 | Velphoro |
| Amicus Therapeutics, INC. | $22.72 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $21.77 | 2023 | Jynarque |
| Genzyme Corporation | $21.35 | 2021 | |
| Calliditas Therapeutics US INC. | $20.55 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.20 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.19 | 2023 | |
| Horizon Therapeutics Plc | $17.09 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chantal Hamlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.